Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod

PLoS ONE - United States
doi 10.1371/journal.pone.0124923
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Comparison of Peripheral Blood Th17 Cells and Associated Cytokines in Fingolimod-Receiving and Untreated Multiple Sclerosis Patients

Turkish Journal of Immunology
2019English

Relapse in Multiple Sclerosis

British Medical Journal
Medicine
2015English

Severe CD4 Lymphocytopenia in Patients With Multiple Sclerosis Treated With Fingolimod

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2018English

Tumefactive Multiple Sclerosis Lesions Under Fingolimod Treatment

Neurology
Neurology
2012English

Pathogenic T Cell Cytokines in Multiple Sclerosis

Journal of Experimental Medicine
MedicineAllergyImmunology
2019English

CD4+ Regulatory T Cell Responses Induced by T Cell Vaccination in Patients With Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Identification of Suitable Reference Genes for Peripheral Blood Mononuclear Cell Subset Studies in Multiple Sclerosis

Scandinavian Journal of Immunology
MedicineImmunology
2015English

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Multiple Sclerosis International
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy